The number of published health economic analyses, especially economic evaluations, has rapidly expanded globally since the 1990s, and costs are an essential component of such studies. Cost is a general term that refers to the value of the resources/inputs used to produce a good or service. However,

Pritaporn Kingkaew1,*, PitsaphunWerayingyong1, San San Aye2, Nilar Tin3, Alaka Singh4, Phone Myint2 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand, 2Department of Health Planning and 3Department of He

11-3-103-2559local authority,primary school,school health services,นักเรียน,บริการอนามัยโรงเรียน,องค์กรปกครองส่วนท้องถิ่น,โรงเรียน

Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff

The objectives of this study are to identify resources used for providing tetravalent dengue vaccine to prevent dengue infection in the Thai health care settingestimate the budget impact of dengue vaccination program nationwide and to conduct economic evaluation of providing tetravalent dengue vaccine program compared with no vaccination program. T

โรคติดเชื้อ Human Papillomavirus (HPV) เป็นโรคติดต่อทางเพศสัมพันธ์ที่พบได้บ่อยและสามารถแพร่กระจายได้ง่ายเพียงการสัมผัสทางผิวหนัง (skin-to-skin contact

การระบาดของโรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19) ทำให้มีผู้ติดเชื้อและเสียชีวิตทั่วโลก ทางออกที่ยั่งยืนของวิกฤตครั้งนี้ คือ การมี

This is a guest post by Moriah Pollock-Hawthorne, Haverford University.I was an intern at NICE International and an American university student with aspirations to become a doctor. In an effort to learn about universal health coverage and experience a single-payer healthcare system in action, I came